John Brophy, MD
Neurological Surgery · Memphis, TNNPI 1013930296
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 22 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Boston Scientific accounts for 79.3% of it on its own, with 4 other manufacturers making up the rest. 2025 is the largest year on record at $251, more than ten times the $25 reported in 2019. That places this record below the midpoint for neurological surgery clinicians in TN, where the typical reported total is $3,083.
Across 22 payments — averaging $17.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$309
- Portola Pharmaceuticals, LLC$25
- AbbVie$24
- Biohaven Pharmaceutical Holding Company Ltd.$17
- Medtronic$14
Across 14 payments — averaging $142,901 each. An ownership or investment interest held by the physician or an immediate family member.
- Alafair Biosciences, Inc.$2M
What the payments were for
- Food & beverage$390100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 18 | $309 |
| Portola Pharmaceuticals, LLC | 1 | $25 |
| AbbVie | 1 | $24 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $17 |
| Medtronic | 1 | $14 |
How this compares
$390 in reported general payments places this provider in the 15th percentile of 156 neurological surgery providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 96 | $883 |
| Pregabalin | 11 | $824 |
| Piroxicam | 18 | $595 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 36 | $465 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 31 | $376 |
| Meloxicam | 69 | $187 |
| Methylprednisolone | 18 | $177 |
| Tramadol Hcl | 13 | $39 |
Paid to pharmacies, not to this prescriber.
Other neurological surgery in Memphis
- Kevin FoleyMemphis$162.4M
- Maurice SmithMemphis$4.4M
- Adam ArthurMemphis$1.9M
- Paul ParkMemphis$1.2M
- Daniel HoitMemphis$607K
- Jason GerrardMemphis$112K
- Earl JonesMemphis$59K
- Demi DawkinsMemphis$56K
- Isaac PomeraniecMemphis$56K
- Kyle SmithMemphis$48K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.